PIM1 and breast carcinoma: In this study, our data showed that Pim1 positively regulates the expressions of HER2 at the transcriptional level and that targeting Pim1 may be a promising and effective therapeutic approach not only for anti-cancer growth but also for circumventing lapatinib resistance in HER2-positive breast cancer patients.